Cash & equivalents decreased 27.8%
Cash & equivalents changed -27.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -27.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed +1425 basis points from the comparable as-filed period.
Gross profit changed +47.9% from the comparable as-filed period.
Inventory changed +68.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +183.4% from the comparable as-filed period.
Operating income changed +170.7% from the comparable as-filed period.
Operating margin changed +2387 basis points from the comparable as-filed period.
Revenue changed +15.6% from the comparable as-filed period.
Stock-based compensation changed -28.1% from the comparable as-filed period.
Research & development changed +16.3% from the comparable as-filed period.
Selling, general & administrative changed -10.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.